Central Venous Catheters and Associated Products

Concepts

• disposable non-chemical medical consumables
• catheters
• catheter accessories
• central venous catheters
• vascular catheters
• catheter fixation / securement devices
• central
• venous
• catheter
• haematological consumables

Location

Various Locations in the UK

Description

As part of its pre-tender strategy, NHS Supply Chain would like to engage with suppliers in relation to the Framework agreement for the supply of Central Venous Catheters and Associated Products including but not limited to Arterial Lines, Arterial Cannula, Central Venous Catheters (Tunnelled / Non-Tunnelled), Catheter Fixation / Securement Devices, Port Introducers, Implantable Ports, Introducers, Tunnelling Rods, Midlines, PICCs, Vascular Catheters, Huber Needles (Safety / Non Safety with / without Y-Site), and Repair Kits. It is anticipated that initial expenditure will be in the region of £28,000,000 to £34,000,000 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. Estimated value over the maximum 4 year Framework Agreement (2+2 Term) will be in the region of £120,000,000 to £136,000,000. Through the use of the RFI, potential suppliers will be able to provide detail on their proposed product solution to the issue which will shape the future approach that NHS Supply Chain will take in ensuring that these options are available throughout the NHS. Current indicative volumes / Contract Values would be unknown as those would be based upon the responses received.

Lot Division

CPV Codes

• 33141000 - Disposable non-chemical medical consumables and haematological consumables
• 33141200 - Catheters
• 33184100 - Surgical implants
• 33141240 - Catheter accessories
• 33141320 - Medical needles

Indicators

• Restrictions apply to the lot award allocation.

Other Information

Please note, following the return of the RFI, NHS Supply Chain reserves the right to contact responding suppliers with clarifications that they may have in relation to the proposed product/solution to enable full understanding. Additionally, please note that this PIN is for market engagement purposes only and NHS Supply Chain provides no guarantees via this PIN of any subsequent tendering activity or purchase of any solution offered. Instructions on how to submit a response to the RFI are listed within the Additional Information section. The purpose of this notice is to draw attention to a procurement that NHS Supply Chain intends to commence during the subsequent 12 months. The invitation to tender will be the subject of a separate notice and it is that notice to which potential suppliers will need to respond at the appropriate time. To review and provide a response to the outlined Request for Information (RFI). Please follow the guidance below: PORTAL ACCESS - Login with URL https://nhssupplychain.app.jaggaer.com// - Click on “SQs Open to All Suppliers” and search for the title of the procurement. SQ_542 - RFI - Central Venous Catheters and Associated Products - The Request for Information Document will be available in the Qualification envelope and attachments tab. The closing date for responses to the RFI will be 23rd August 2024. Please note - although NHS Supply Chain provides no guarantees of any potential future tendering opportunity as part of this PIN process, it may be appropriate for any interested suppliers to be aware of the tendering requirements outlined below which would form a minimum expectation of any tender submission (where relevant to the solution): - ISO 9001: 2015 accredited by the United Kingdom Accreditation Service (or equivalent) to cover all segments of the Applicant’s and the product’s supply chain. This should include, but not be limited to, manufacturing, storage and distribution. If Quality Assurance Standard certificates are not in the name of the Applicant then the Applicant must supply a copy of agreements setting out the authority and responsibilities of all parties in the supply chain. - Declaration of Conformity and UKCA Certification to demonstrate compliance to UK Medical Device Regulations 2002 or Declaration of Conformity and CE Certification to d-Declaration of Conformity and UKCA Certification to demonstrate compliance to UK Medical Device Regulations 2002 or Declaration of Conformity and CE Certification to demonstrate compliance to Medical Devices Directive 93/42/EEC or Medical Device Regulation 2017/745 (where applicable). - MHRA registration of any medical devices, in compliance with the Medical Devices Regulations 2022 (SI 2022 No 618, as amended) (UK MDR 2022). - The Insurance set out below, acceptable evidence of which should be an Insurance Certificate or a signed Broker’s letter. > Employers liability Insurance cover of £5m per claim > Public Liability Insurance cover of £5m per claim > Product Liability Insurance cover of £5m NHS Supply Chain will assess the Applicant’s economic and financial standing (or that of the entity or entities the Applicant is relying upon). Documentary evidence of this will be required at tender stage. All Applicants for this future tender must have a compliant Carbon Reduction Plan to be considered for the Framework Agreement (PPN 06/21). This future Framework Agreement will include some qualitative evaluation questions on Social Value with a minimum weighting of 10% towards the award (PPN 06/20). All Applicants bidding to be on any NHS Supply Chain Frameworks must submit an Evergreen Assessment as part of the tendering process. This must be completed annually, and the maturity score will be valid for 12 months. https://www.england.nhs.uk/nhs-commercial/central-commercial-function-ccf/evergr... As a minimum (and further requirements may be set out in the tender documents), Applicants are required to have a Modern Slavery Assessment (MSAT) completed within 12 months of the tender close date (PPN 02/23). NHS Supply Chain expects to provide successful suppliers with the opportunity to offer additional savings to customers through the provision of discounted pricing, value added offerings and commitment/bulk buy initiatives.